New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder

World Journal of Urology

Volumn 15, Issue 2, 1997, Pages 125-133

  Warde, P ^a,b   Gospodarowicz, M K ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER TUMOR; CANCER INVASION; HUMAN; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; RADIOLOGY; REVIEW; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM INVASIVENESS; PATIENT SELECTION; TECHNOLOGY, RADIOLOGIC; URINARY BLADDER NEOPLASMS;

EID: 0030631002     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02201984     Document Type: Article

References (61)

1. Ang K. Trotti A, Garden A, Foote R. Morrison W, Geara F. Peters L (1996) Overall time factor in postoperative radiation: results of a prospective randomized trial. Radiother Oncol 40 Suppl 1: S30
2. Blandy JP. England HR. Evans SJW, Hope SHF, Mair GMM. Mantell BS. Oliver RTD. Paris AMI. Risdon RA (1980) T3 Bladder cancer-the case for salvage cystectomy. Br J Urol 52: 506-510
3. Blandy JP. Jenkins BJ. Fowler CG. Caulfield M. Badenoch DF. England HR, Hope-Stone HF. Mair CM. Mantell BS. Oliver RT. et al (1988) Radical radiotherapy and salvage cystectomy for T2 3 cancer of the bladder. Prog Clin Biol Res 260: 447-451
4. Bristow R. Benchimol S. Hill RP (1996) The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol (in press)
5. Coleman CN, Stevenson MA (1996) Advances in cellular and molecular radiation oncology. Urol Onco 2: 3-13
6. Coppin C. Brown E (1986) Concurrent cisplalin with radiation for locally advanced bladder cancer: a pilot study suggesting improved survival. Proc Am Soc Clin Oncol 5: 99
7. Coppin C. Gospodarowicz MK. James K, Tannock IF, Zee B. Pater J. Sullivan ED (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14: 2901-2907
8. Davidson SE, Symonds RP, Snee M P. Upadhyay S, Habeshavv T. Robertson AG (1990) Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol 66: 288 293
9. Duncan W, Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7: 299-310
10. Dunst J. Sauer R, Schrott KM, Kühn R. Wittenkind C. AItendorf-Hofman A (1994) Organ sparing treatment of advanced bladder cancer: a 10 year experience. Int J Radiât Oncol Biol Phys 30: 261-266
11. Eapen L, Stewart D, Crook J. Aitken S. Danjoux C. Rasuli P. Peterson R (1992) Intraarterial cisplatin and concurrent pelvic radiation in the management of muscle invasive bladder cancer. Int J Radiât Oncol Biol Phys 24 [Suppl I]: 211
12. Evans PE. Swanson DA, (1996) What to do if the lymph nodes are positive. Semin Urol Oncol 14: 96-102
13. Fossa SD. Waehre H. Aass N, Jacobsen AB, Olsen DR, Ous S (1993) Bladder cancer: definitive radiation therapy of muscleinvasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72: 3036-3043
14. Fujiwara T, et al (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral mediated transfer of the wild type p53 gene. Cancer Res 54: 2287-2291
15. Fung CY, Shipley WU, Young RH, Griffin PP. Convery KM, Kaufman DS. Althausen AF, Heney NM, Prout GR Jr (1991) Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy [see comments]. J Clin Oncol 9: 1533-1542
16. Fyles A, Keane T. Barton M, Simm J (1992) The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 25: 273-279
17. Gospodarowicz MK, Hawkins NV. Rawlings GA, Connolly JG, Jewett MAS, Thomas GM, Herman JG, Garrett DG. Chua T, Duncan W, Buckspan M, Sugar L, Rider WD (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis. J Urol 142: 1448-1454
18. Gospodarowicz MK, Rider WD. Keen CW. Connolly JG. Jewett MAS, Cummings BJ, Duncan W, Warde P. Chua T (1997) Bladder cancer: long term follow-up results of patients treated with radical radiation. Clin Oncol 3: 155-161
19. Gospodarowicz MK, Quilty PM. Scalliet P, Tsujii H, Fossa SD, Horenblas S, Isaka S, Prout GR, Shipley WU, Wijnmaalen AJ. et al (1995) The place of radiation therapy as definitive treatment of bladder cancer (review). Int J Urol 41: 41-48
20. Hall R (1996) Néo-adjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer. First analysis of MRC/EORTC intercontinental trial. Proc Am Soc Clin Oncol 15: 244
21. Hallahan DE, Maucera HJ, Seug LP, et al (1995) Spatial and temporal control of gene therapy using ionising radiation. Nat Med 1: 786-791
22. Honnens DE, Lichtenberg M, Miskowiak J, Rolff H (1995) Results of radiotherapy on ureteric obstruction in muscle-invasive bladder cancer. Br J Urol 75: 197-199
23. Horiot J, Bontemps P, Le Fur R, Bogaert W van de, Bolla M, Weijngaert D van, Bernier J, Lusinchi A, Stuschke M. Lopez Torrecilla D, Collette L, Pierart M (1996) An overview of the EORTC accelerated and hyperfractionated radiotherapy trials in head and neck cancers. Radiother Oncol 40 [Suppl lj: S30
24. Housset M, Maulard C, Chrétien Y, Dufour B, Delanian S, Huart J. Colardelle F, Brunei P, Baillet F (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150-2157
25. Jacobsen AB, Pettersen EO, Amellem O. Berner A, Ous S, Fossa SD (1992) The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J Urol 147: 34-37
26. Jakse G, Frommhold H (1985) Radiotherapy and chemotherapy in locally advanced bladder cancer. Eur Urol 14 [Suppl 1]: 45
27. Jenkins BJ, Martin JE, Baithun SI, Zuk RJ, Oliver RTD, Blandy JP (1990) Prediction of response to radiotherapy in invasive bladder cancer. Br J Urol 65: 345-348
28. Koratim M, Kamal B, Metwalli N, Zaky Y (1995) Transurethral ultrasonographic assessment of bladder carcinoma: its value and limitation. J Urol 154: 375-378
29. Lynch W. Jenkins BJ. Fowler CG, Hope SH. Blandy JP (1992) The quality of life after radical radiotherapy for bladder cancer. Br J Urol 70: 519-521
30. Malmstrom PU. Lonnemark M, Busch C, Magnusson A (1993) Staging of bladder carcinoma by computer tomographyguided transmural core biopsy. Scand J Urol Ncphrol ">?· 193 198
31. Mameghan H. Fisher R. Mameghan J, Brook S (1995) Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiât Oncol Biol Phy 31: 247-254
32. Martin JE. Jenkins BJ, Zuk RJ. Oliver RT. Baithun SI (1989) Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virchows Arch [A] 414: 273-277
33. Monzen Y, Mori H. Matsumoto S. Takaki H, Yoshida S. Wakisaka M, Ueda S. Mizoguchi H, Ogata J, Kato Y (1995) Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report. Radiât Med 13: 149-152
34. Moonen LM. Horenblas S, Voet JC van der. Nuyten MJ, Bartelink H (1994) Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and indium-192 implantation. Br J Urol 74: 322-327
35. Moore MJ, O'Sullivan B. Tannock IF (1988) How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6: 1736-1745
36. Naslund I, Nilsson B, Littbrand B (1994) Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol 33: 397-402
37. Overgaard J (1994) Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumours. Oncol Res 6: 509-518
38. Pagano F. Bassi P. Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumour, nodes and métastases classification. J Urol 145: 45-50
39. Paschkis R (1911) Radiumbehandlung von Blasengeschwulsten. Wien Klin Wochenschr 24: 1962
40. Pisters LL, Tykochinsky G. Wajsman Z (1991) Intravesical bacillus Calmette-Guérin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. J Urol 146: 1514-1517
41. Plataniotis G. Michalopoulos E, Kouvaris J, Vlahos L, Papavasiliou C (1994) A feasibility study of partially accelerated radiotherapy for invasive bladder cancer. Radiother Oncol 33: 84-87
42. Pollack A, Zagars GK, Dinney CP, Swanson DA, von Escrenbach AC Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer 74: 2819-2827
43. Pollack A, Zagars GK, Swanson DA (1994) Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiât Oncol Biol Phys 30: 267-277
44. Pollack A, Zagars GK. Cole CJ. Dinney CPN. Swanson DA, Crossman HB (1995) The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 154: 2059-2064
45. Priesler H. Kotelnikov V. LaFollette S. Taylor S, et al (1996) Continued malignant cell proliferation in head and neck tumours during cytoxic therapy. Clin Cancer Res 2: 1453-1460
46. Quilty PM, Duncan W (1986) Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiât Oncol Biol Phys 12: 861-865
47. Quilty PM, Kerr GR, Duncan W (1986) Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7: 311-321
48. Roth JA. et al (1996) Retrovirus-mediated wild type p53 gene transfer to tumours of patients with lung cancer. Nat Med 2: 985-987
49. Rotman M, Aziz H. Porrazzo M. Choi K, Silverstein M. Rosenthal J. Laungani G, Macchia R (1990) Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. Int J Radiât Oncol Biol Phys 18: 1131-1137
50. Russell K.J. Boileau MA, Higano C. Collins C. Russell AH. Koh W, Cole SB, Chapman WH. Griffin TW (1990) Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder [see comments]. Int J Radiât Oncol Biol Phys 19: 693-699
51. Sauer R. Dunst J, Altendorf-Hofmann A, Fischer H, Bornhof C. Schrott KM (1990) Radiotherapy with and without cisplatin in bladder cancer. Int J Radial Oncol Biol Phys 19: 687691
52. See WA, Fuller JR (1992) Staging of advanced bladder cancer. Current concepts and pitfalls (review). Urol Clin North Am 19: 663-683
53. Shipley WU. Coombs LJ, Einstein AB Jr. Soloway MS, Wajsman Z, Prout G Jr. et al (1984) Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol 132: 899 903
54. Shipley WU, Kaufman DS. Griffin P, Althausen AF. Heney NM. Prout GJ (1992) Radio-chemotherapy for invasive carcinoma of the bladder (review). FYont Radiât Ther Oncol 26: 142-152
55. Smaaland R. Akslen L. Tender B. Mehus A, Lote K, Albrektsen G (1991) Radical radiation treatment of invasive and locally advanced bladder cancer in elderly patients. Br J Urol 67: 61-69
56. Tannock I (1996) The treatment of cancer with radiation and drugs. J Clin Oncol (in press)
57. Tester W. Porter A. Asbell S, Coughlin C, Heaney J, Martz K. Venner P, Hammond E (1989) Combined modality program with possible organ preservation for invasive bladder carcinoma: preliminary results of RTOG protocol 8512. Proc Am Soc Clin Oncol 8: \4\
58. Turner SL, Swindell SL. Bowl N, et al (1994) Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiât Oncol Biol Phys 30: 81
59. Vale JA, A'Hern RP, Liu K. Hendry WF. Whitfield HN. Plowman PN. Sowter C. Slavin G (1993) Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur Urol 24: 48-51
60. Wolf H. Olsen PR, Hojgaard K (1985) Urothehal dysplasia concomitant with bladder tumours: a determinant for future new occurrences in patients treated by full-course radiotherapy. Lancet II: 1005-1008
61. Zietman AL. Shipley WU (1994) Organ-sparing treatment for bladder cancer: time to beat the drum (editorial). Int .1 Radial Oncol Biol Phys 30: 741-742